Royal DSM reports a “solid first nine months in a challenging Covid-19 environment,” with a continuing robust performance in Q3, despite significant adverse foreign exchange effects. According to the company, group sales stable and adjusted Ebitda was down by 3 %. Nutrition sales increased by 4 % and organic sales were up 5 %. Overall, the adjusted net profit was down 8 % to EUR 544 m. Total group net profit was EUR 453 m. DSM reported “a solid Q3” despite significant adverse foreign exchange effects.

“The first nine months of 2020 were impacted by the Covid-19 pandemic, with Nutrition overall performing well in this environment and Materials significantly affected,” Geraldine Matchett and Dimitri de Vreeze, co-CEOs, explain. “During this period, we have taken timely actions to protect profitability and cash flow generation, while we continued to execute our long term strategy. We closed two acquisitions in Nutrition, including the Erber Group in October, and announced the divestment of our Resins and Functional Materials businesses.”